Literature DB >> 1656542

Cellular regulation of fibrinolysis.

E F Plow, J Felez, L A Miles.   

Abstract

By virtue of their capacity to bind plasminogen activators and plasminogen, to accelerate plasminogen activation and to protect bound plasmin from inactivation by alpha 2 antiplasmin, cells can harness the broad proteolytic activity of plasmin to their surface. Most cells bind plasminogen with a very high capacity, a relatively low affinity (Kd approximately 1 microM) and recognize the lysine binding sites of the molecule. Gangliosides serve as non-protein plasminogen binding sites, and a subset of membrane proteins with carboxy-terminal lysine residues also serve as receptors. The alpha isoform of enolase possesses a carboxy-terminal lysine and is a prominent plasminogen binding protein of cells. Cells of the monocytoid lineage, including peripheral blood monocytes, can markedly upregulate their expression of plasminogen receptors. The capacity to modulate expression of receptors for fibrinolytic components establishes an additional mechanism by which the cell-surface regulates the function of the plasminogen system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656542

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  23 in total

1.  Enolase as a plasminogen binding protein in Leishmania mexicana.

Authors:  Gilmer Vanegas; Wilfredo Quiñones; Cesar Carrasco-López; Juan Luis Concepción; Fernando Albericio; Luisana Avilán
Journal:  Parasitol Res       Date:  2007-07-27       Impact factor: 2.289

2.  Carboxypeptidases: new regulators of plasminogen activation in vivo?

Authors:  D J Loskutoff
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells.

Authors:  Lin Yu; Jiandang Shi; Sa Cheng; Yan Zhu; Xiulan Zhao; Kuo Yang; Xiaoling Du; Helmut Klocker; Xiaoli Yang; Ju Zhang
Journal:  Mol Endocrinol       Date:  2012-06-25

Review 4.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

5.  Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase.

Authors:  S Namiranian; Y Naito; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

6.  Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular Carcinoma.

Authors:  Pierpaolo Calandro; Giulia Iovenitti; Claudio Zamperini; Francesca Candita; Elena Dreassi; Mario Chiariello; Adriano Angelucci; Silvia Schenone; Maurizio Botta; Arianna Mancini
Journal:  ACS Med Chem Lett       Date:  2018-05-07       Impact factor: 4.345

Review 7.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

Review 8.  Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2012-10-05       Impact factor: 7.376

Review 9.  Thrombolytic therapy in the treatment of stroke.

Authors:  G J del Zoppo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

10.  Immunogenic and plasminogen-binding surface-associated alpha-enolase of Trichomonas vaginalis.

Authors:  V Mundodi; A S Kucknoor; J F Alderete
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.